Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
Author:
Affiliation:
1. Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
2. Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA
Funder
Navigate Biopharma
Yale SPORE in Skin Cancer
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1864909
Reference43 articles.
1. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
3. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
4. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
5. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer;Cancers;2024-09-11
2. Prognostic value of CMTM6 protein in hepatocellular carcinoma involving the regulation of the immune microenvironment;International Journal of Biological Macromolecules;2024-08
3. CMTM6 promotes hepatocellular carcinoma progression through stabilizing β-catenin;Cancer Letters;2024-02
4. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors;PeerJ;2024-01-10
5. Molecular and immunological characteristics of patients with CMTM6 low expression colorectal cancer;Medicine;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3